TherapeuticsMD Inc expected to post a loss of 7  cents a share - Earnings Preview

TherapeuticsMD

08/03/2022 14:32

* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show
a rise
in quarterly revenue when it reports  results on March 10. 
    * The Boca Raton Florida-based  company is expected to
report  a
28.4% increase in revenue to $28.985 million from $22.58 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TherapeuticsMD Inc
is for
a loss of 7 cents per share. For the same quarter last year, the
company reported a loss of 15 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $5​, about 94% above​ its last closing price
of $0.30. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.10       -0.10      -0.11     Missed  -10
 Jun. 30 2021  -0.11       -0.11      -0.11     Met     0
 Mar. 31 2021  -0.12       -0.12      -0.11     Beat    5.2​
 Dec. 31 2020  -0.11       -0.10      -0.15     Missed  -42.9
 ​​Sep.        -0.14       -0.14      -0.12     Beat    12.2
 30 2020                                                
 Jun. 30 2020  -0.17       -0.17      -0.19     Missed  -10.7​
 Mar. 31 2020  -0.19       -0.19      -0.21     Missed  -12
 Dec. 31 2019  -0.19       -0.19      -0.19     Met     -1.5
 This summary was machine generated March 8 at 14:32 GMT.  All
figures in US dollars  unless otherwise stated